CIK 0001640266 · Accelerated filer<br>Smaller reporting company
Voyager Therapeutics, Inc.
Sign in to watch- Ticker
- VYGR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-259-5340
- Business address
- 75 HAYDEN AVENUE, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-03 | PIERCE GLENN Director | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2025-06-03 | Onyia Jude Director | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2025-06-03 | MACKEY CATHERINE J Director | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2025-06-03 | Hyman Steven Director | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2025-06-03 | Higgins Michael J Director | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2025-06-03 | GERAGHTY JAMES A Director | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2025-06-03 | Colon Grace Director | Grant or award · Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2025-04-02 | Ferguson Toby Chief Medical Officer | Sale | −10,086 | $3.43 | $35K | 157,914 |
| 2025-04-02 | Sandrock Alfred President and CEO | Sale | −10,885 | $3.43 | $37K | 430,931 |
| 2025-02-21 | Carter Todd Alfred Chief Scientific Officer | Grant or award | +46,000 | 123,718 | ||
| 2025-02-21 | Carter Todd Alfred Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +92,000 | 92,000 | ||
| 2025-02-21 | Sandrock Alfred President and CEO | Grant or award | +145,000 | 441,816 | ||
| 2025-02-21 | Sandrock Alfred President and CEO | Grant or award · Stock Option (Right to Buy) | +290,000 | 290,000 | ||
| 2025-02-21 | Swartz Robin COO & CBO | Grant or award | +71,250 | 169,647 | ||
| 2025-02-21 | Swartz Robin COO & CBO | Grant or award · Stock Option (Right to Buy) | +142,500 | 142,500 | ||
| 2025-02-21 | Fahey Sandell Jacquelyn Chief Legal Officer | Grant or award | +41,500 | 123,143 | ||
| 2025-02-21 | Fahey Sandell Jacquelyn Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +83,000 | 83,000 | ||
| 2025-02-21 | Ferguson Toby Chief Medical Officer | Grant or award | +63,000 | 168,000 | ||
| 2025-02-21 | Ferguson Toby Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +126,000 | 126,000 | ||
| 2025-02-21 | Jorgensen Nathan D. Chief Financial Officer | Grant or award | +51,500 | 131,500 |
Page 3 of 7 · 130 trades